MetaCap

Cellebrite DI Cash Flow Statement

NASDAQ: CLBTTechnologyComputer Software: Prepackaged SoftwareUSD

11.26-0.08 (-0.71%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Cellebrite DI free cash flow

In fiscal 2025, Cellebrite DI generated $173.5 million of operating cash flow and spent $13.2 million on capital expenditures. That left free cash flow of $160.3 million, a free-cash-flow margin of 33.7% of revenue. Free cash flow was up 29.7% from the prior year's $123.6 million.

Summary generated from market data by MetaCap's automated system. Methodology

Cellebrite DI cash flow statement (annual)

Cellebrite DI annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20222023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31
Net Income78.33M-283.01M-81.10M120.81M71.40M5.78M-1.88M
Net Income growth (YoY)——-167.13%+69.20%+1135.01%——
Depreciation & Amortization11.87M10.61M10.01M9.19M7.01M5.88M4.08M
Stock-Based Compensation44.89M30.57M19.00M13.71M6.48M7.27M12.76M
Change in Working Capital46.18M23.43M43.11M11.24M13.98M26.22M2.25M
Operating Cash Flow173.54M132.17M102.06M20.58M36.05M66.51M16.13M
Capital Expenditures-13.22M-8.57M-5.23M-6.90M-5.11M-6.18M-6.21M
Investing Cash Flow-268.25M-149.47M-22.54M-91.23M45.23M-6.45M-46.72M
Dividends Paid——00-100.00M-10.00M-25.00M
Share Repurchases———00-85.00K-808.00K
Financing Cash Flow25.05M20.65M21.77M13.97M-68.40M-8.59M75.54M
Net Change in Cash-69.65M3.35M101.28M-56.68M12.88M51.47M44.95M
Free Cash Flow160.32M123.61M96.83M13.68M30.94M60.33M9.92M

This table shows 7 annual periods of Cellebrite DI's cash flow statement, from FY 2025 back to FY 2019, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CLBT's reporting calendar. What is a cash flow statement?

More financial data